26 May 2013
Keywords: icn, pharma, unit, ribapharm, files, s-1, amendment
Article | 01 April 2002
US firm ICN Pharmaceuticals' subsidiary Ribapharm has filed an amendedS-1 registration statements with the Securities and Exchange Commission to proceed ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.